Recombinant Mouse BST2 protein (mFc Tag)

种属

Mouse

纯度

>90 %, SDS-PAGE

标签

mFc Tag

生物活性

未测试

Cat no : Eg4042

Print datasheet

Synonyms

Bone marrow stromal antigen 2, BST-2, CD317, HM1.24 antigen



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Mouse BST2 protein Thr52-Ser152 (Accession# Q8R2Q8) with a mouse IgG Fc tag at the C-terminus.
基因ID 69550
蛋白编号 Q8R2Q8
预测分子量 38.0 kDa
SDS-PAGE 42-52 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

BST2, also named as CD317 and Tetherin, belongs to the tetherin family. It may be involved in the sorting of secreted proteins and it is involved in pre-B-cell growth. BST2 is an antiretroviral defense protein, that blocks retrovirus release from the cell surface. Depleted upon HIV-1 infection by viral VPU protein through 20S proteasome degradation. Depleted upon infection by human Kaposi's sarcoma-associated herpesvirus (KSHV) through ubiquitination and subsequent degradation. BST2 may play a role in B-cell activation in rheumatoid arthritis. It is recently identified interferon-induced cellular proteins that restrict infections by retroviruses and filoviruses and of influenza virus and flaviviruses, respectively. BST2 is a plasma membrane protein, tetherin inhibits virion particle release from infected cells. BST2 is effective against retroviruses and flavoviruses whilst IFITMs disrupt influenza and flavivirus infection.

参考文献:

1.Miyagi E, et al. (2019) Proc Natl Acad Sci U S A. 24;106(8):2868-73. 2.Skasko M, et al. (2011) Virology. 1;411(1):65-77. 3.Andrew AJ, et al. (2009) Retrovirology. 8;6:80. 4.Tanwattana N, et al. (2023) PLoS One.3;18(11):e0292833.

||
New chat Able
正在加载,请稍候...